Nathaniel David

Nathaniel ‘Ned’ David is the CEO of UNITY Biotechnology, which he co-founded in 2011. Prior to UNITY, Ned co-founded four other biotechnology companies that together raised over $1.5 billion in financing, launched two FDA-approved medicines, and today employ over 400 scientists, engineers, and business people. Ned builds companies because he sees company creation as a means to create technologies that change the world. Ned was named one of the Top 100 innovators in the world under 35 by the MIT Technology Review. He holds a PhD from the University of California, Berkeley in Molecular and Cellular Biology and an AB in Biology from Harvard University.